AlphaYouJL
Insider selling
Jason Lettmann sold $4K of Alx Oncology Holdings Inc (ALXO) stock
Jason Lettmann, Chief Executive Officer of Alx Oncology Holdings Inc (ALXO), sold 2,230 shares of ALXO stock worth $4K, per an SEC Form 4 filed Aug 18, 2026.
It was an open-market sale.
The trade happened on Aug 17, 2026, 1 day before it was made public.
ALXO has moved -15.7% since the trade date, from $1.97 to $1.66 (Sep 21, 2026 close).
- Traded
- Aug 17, 2026
- Disclosed
- Aug 18, 2026
- Filing delay
- 1 day
- Price since
- -15.7%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More ALXO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.